Citadel Advisors
SRTA

Citadel Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Citadel Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66K Buy
+15,800
New +$76K ﹤0.01% 12285
2025
Q3 		– Sell
-21,400
Closed -$86.2K – 12784
2025
Q2 		$86.2K Buy
+21,400
New +$69.7K ﹤0.01% 11439
2025
Q1 		– Sell
-9,400
Closed -$40K – 14501
2024
Q4 		$40K Buy
9,400
+9,300
+9,300% +$35.4K ﹤0.01% 12612
2024
Q3 		$294 Sell
100
-10,500
-99% -$33.4K ﹤0.01% 14053
2024
Q2 		$36.9K Sell
10,600
-17,100
-62% -$57K ﹤0.01% 12069
2024
Q1 		$78.9K Sell
27,700
-78,600
-74% -$242K ﹤0.01% 11672
2023
Q4 		$375K Buy
106,300
+43,700
+70% +$125K ﹤0.01% 8697
2023
Q3 		$162K Sell
62,600
-20,600
-25% -$72.4K ﹤0.01% 10233
2023
Q2 		$328K Buy
83,200
+29,300
+54% +$93K ﹤0.01% 8855
2023
Q1 		$182K Sell
53,900
-32,300
-37% -$132K ﹤0.01% 10333
2022
Q4 		$309K Sell
86,200
-11,000
-11% -$47K ﹤0.01% 9256
2022
Q3 		$392K Sell
97,200
-12,100
-11% -$62.1K ﹤0.01% 8986
2022
Q2 		$487K Buy
109,300
+1,600
+1% +$11.5K ﹤0.01% 8719
2022
Q1 		$914K Buy
107,700
+10,400
+11% +$73.1K ﹤0.01% 7928
2021
Q4 		$859K Sell
97,300
-100,000
-51% -$950K ﹤0.01% 8329
2021
Q3 		$2.05M Buy
197,300
+32,100
+19% +$280K ﹤0.01% 6280
2021
Q2 		$1.74M Sell
165,200
-281,800
-63% -$2.78M ﹤0.01% 6945
2021
Q1 		$4.6M Buy
+447,000
New +$6.22M ﹤0.01% 4432

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's SRTA Position: Q1 2026 in Review

Citadel Advisors increased its Strata Critical Medical Inc (SRTA) stake by 46% in Q1 2026, buying an estimated $569K and bringing the position to 372,941 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #6631.

Citadel Advisors first reported a position in SRTA in Q4 2020 and has held it in 21 quarters since. The position peaked at $4.01M in Q4 2024. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Citadel Advisors held 372,941 shares of Strata Critical Medical Inc worth $1.56M as of Q1 2026.
  • Citadel Advisors bought 118,130 Strata Critical Medical Inc shares in Q1 2026, an estimated $569K.
  • Strata Critical Medical Inc made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6631 holding.
  • Citadel Advisors first reported a position in Strata Critical Medical Inc in Q4 2020 and has held it in 21 quarters since.
  • Citadel Advisors's Strata Critical Medical Inc position peaked at $4.01M in Q4 2024.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.